MAP - Market Access Podcast

Dr. Stefan Walzer

Market Access (or alternatively reimbursement) in health care is THE key competence in order to be commercially successful with a new drug, medical device or digital health application. However, given the fact that market access is a complex field involving various disciplines and is an ever-changing field, it is difficult to be up to speed with the different evolvements across the world. MAP is THE bi-weekly Market Access Podcast provided by MArS Market Access & Pricing Strategy, which is your health care consultancy in the German-speaking markets and allows you to keep up to date with market access , reimbursement and pricing issues in the D-A-CH countries and around the world. With MAP you will get a summary of core market access systems and processes as well as latest changes in regulations including statements and opinions of core decision makers and stakeholders from various countries. The CEO and founder of MArS is also the driver behind MAP: Dr. Stefan Walzer works in the field of payer strategy, pricing, health economics and reimbursement since 2004 and is the founder and CEO of MArS Market Access & Pricing Strategy GmbH based in Germany. MArS makes it as easy as possible for you to get your Pharmaceutical, MedTech or digital health product to the market and of course get the price it deserves. Stefan previously worked as a payer consultant for various global pharmaceutical and medical device / diagnostic companies, successfully launching their products across the world. He was the Global Payer Strategy Leader for various products and compounds at F. Hoffmann – La Roche AG, where he successfully developed early payer strategies as well as launching and maintaining the reimbursement process for top brands and early compounds. Stefan is capable in translating the clinical and economic evidence into successful reimbursement submissions and pricing negotiations especially in Austria, Germany and Switzerland. Additionally he teaches market access, pricing and negotiations at the State University of Baden-Wuerttemberg and the University of Applied Sciences Weingarten-Ravensburg (both Germany). Besides other roles and responsibilities. Stefan was the head of the committee “Inpatient care” of the German Health Economic Association (DGGÖ). Furthermore he is also a member of the Austrian Health Economic Association (ATHEA) and the Swiss Health Economic Association (SGGÖ). Additionally, he is a member of the Access Advisory Committee of the Global Pneumonia Prevention Coalition. Stefan received a Master of Science in Economics from the University of Tuebingen (Germany), a PhD in Health Economics from the University of Zurich (Switzerland) and a post-graduate diploma in Clinical Trials from the London School of Hygiene and Tropical Medicine (UK). He is co-author of more than 40 peer-reviewed scientific articles and more than 300 scientific abstracts. read less
BusinessBusiness

Episodes

How has virtual become reality in market access, Glib Kutepov?
May 1 2024
How has virtual become reality in market access, Glib Kutepov?
What role will AI & VR transformations play in the future? Tune in to this fascinating episode of the Market Access Podcast to hear as our special guest, Glib Kutepov, CEO and founder of Modulate, shares his expertise. Glib uncovers the potential of generative AI and neural networks in revolutionizing market access strategies and highlights the challenges and solutions around data privacy as well as the integration of private layers to protect sensitive information. He also touches on the role of VR in empathizing with patients' experiences, adding a deeply human element to the data-driven world of market access. This episode will not only provide a deeper understanding for the technology, but also tools of practical ways to implement it.AI and VR could change the data driven health care in the future, as it can benefit the strategic work as well as assist in ensuring a better understanding for the patients’ experiences. Whether you're a healthcare professional, market access manager, or tech enthusiast, this conversation offers a glimpse into a future where technology enhances our approach to healthcare on multiple levels.Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP PodcastsMAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de#HealthcareInnovation #MarketAccess #marketaccesspodcast #ArtificialIntelligence #VirtualReality #FutureOfHealthcare #marketaccess
What Makes Italy's Healthcare System So Complex, Giacomo Matteo Bruno?
Apr 16 2024
What Makes Italy's Healthcare System So Complex, Giacomo Matteo Bruno?
Tune into a brand new episode of the Market Access Podcast to listen to an intriguing conversation about the Italian healthcare system with Giacomo Matteo Bruno and Dr Stefan Walzer. Together they explore the balance between innovation, sustainability, and patient access in the heart of Europe. Discover the evolution, challenges, and future of healthcare in Italy, from the foundational principles laid down in 1978 to the dynamic, ever-evolving landscape of today.Giacomo shares his insights on how to navigate the crucial role of health economics in drug pathways as well as giving a birds-eye perspective over the healthcare system in Italy today and the challenges that comes with an aging population and rising chronic diseases. Giacomo presents a vision for embracing innovation while maintaining the system’s integrity. If you are searching for deeper knowledge about the Italian healthcare system and learn about strategies on how to enter the Italian market, this episode is for you. Learn about the regional nuances that make Italy unique, the steps for drug reimbursement, and the importance of targeted therapies in personalized medicine. Giacomo also sheds light on the pioneering electronic dossier system introduced by IFA, streamlining the approval process and setting a new standard in healthcare innovation.Whether you're a healthcare professional, a pharmaceutical company, or just intrigued by the global healthcare landscape, this conversation offers valuable lessons and strategies for success in one of the world's most revered healthcare systems. Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP PodcastsMAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de#HealthcareInnovation #MarketAccess #Italy #ItalianHealthcare #PharmaceuticalIndustry #marketaccesspodcast #marketaccess
Is Healthcare Just a Business in the US, Aymeric Chaupin?
Apr 1 2024
Is Healthcare Just a Business in the US, Aymeric Chaupin?
In this captivating episode of MAP, the Market Access Podcast, we welcome Aymeric Chaupin, a seasoned expert in pricing and market access. Aymeric's unique perspective, shaped by his deep understanding of both the American and European healthcare systems, sheds light on the complexities of healthcare reimbursement pathways in the US and their impact on the delivery of health services.Join us as Aymeric unveils the challenges and opportunities within the US healthcare market. He emphasizes the importance of coding and understanding reimbursement pathways for effective market access and explores the broader implications for patient care and the healthcare system as a whole.This episode is a treasure trove of insights for startups and companies looking to navigate the US healthcare landscape. Aymeric shares practical advice on entering the market, from partnering with pharmaceutical giants to engaging with the FDA early in the clinical trial process. He stresses the necessity of having a clear strategy and representation in the US to negotiate coverage and formulary placement, ensuring commercial success in this pivotal market.Despite the hurdles, the US remains a key player in the global pharmaceutical and medical device industry, accounting for a significant portion of global revenue.Tune in for an enlightening discussion that navigates the intricacies of the US healthcare system, providing valuable lessons and strategies for companies aspiring to make their mark in this challenging yet rewarding market.#HealthcareInnovation #MarketAccess #US #USHealthcareSystem #PharmaceuticalIndustry #MedicalDevices #HealthcareReform #marketaccess #marketaccesspodcast
Mastering US Market Access: What are proven Strategies for Success, Paul-Lukas Hoffschmidt?
Mar 1 2024
Mastering US Market Access: What are proven Strategies for Success, Paul-Lukas Hoffschmidt?
In this essential episode of the Market Access Podcast, we're diving deep into the critical aspects of commercializing healthcare innovations in the US market. Whether you're in medtech, pharma, biotech, or health tech, understanding the US healthcare landscape is key to your product's success. Join us as Dr. Stefan Walzer and Paul-Lukas Hoffschmidt, CEO of Alpha Sophia (www.alphasophia.com), share their wealth of knowledge on effective strategies for navigating this complex terrain.Key Topics Covered:Understanding US Market Access: An overview of the unique challenges and opportunities in the US healthcare system for new entrants.Role of Healthcare Professionals: Insight into how healthcare professionals influence market access and product uptake.Data-Driven Strategies: The importance of leveraging data in targeting and positioning your product effectively.Commercialization Pathways: Expert advice on navigating regulatory, reimbursement, and distribution challenges.Case Studies: Real-world examples of successful market entry and the lessons learned.Future Trends: Predictions on how the US market access landscape may evolve and what it means for healthcare innovators.Why You Should Listen:Gain Expert Insights: Learn from leading experts with firsthand experience in the US healthcare market.Strategic Advice: Receive actionable advice on overcoming the hurdles to market entry and expansion.Stay Ahead: Understand the latest trends and how they impact market access strategies.This episode is indispensable for CEOs, entrepreneurs, market access professionals, and anyone involved in the commercialization of healthcare innovations looking to penetrate or expand their presence in the US market.Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP PodcastsMAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de#Medtech #MarketAccess #US #HealthcareSystem #MarketAccessPodcast
Beyond the CE Mark: How can we achieve Medtech Reimbursement in France, Dr. Benoit Salaun?
Feb 15 2024
Beyond the CE Mark: How can we achieve Medtech Reimbursement in France, Dr. Benoit Salaun?
Join us for a fascinating dive into the complexities of French market access with our latest episode of the Map Podcast. Dr. Stefan Walzer, health economist and founder of Mars Market Access & Pricing Strategy, engages with Dr. Benoit Salaun, a seasoned expert in French healthcare reimbursement.They unravel:The nuances of the French healthcare systemThe essentials of medical device reimbursementThe importance of demonstrating efficacy, safety, and affordabilityThe role of clinical evidence and the adaptability of international data to French contextsThe strategic considerations for medtech companies entering the French marketWhether you’re a healthcare professional, a medtech innovator, or a market access strategist, this episode is packed with insights on how to ensure your medical device not only enters the French market but also achieves the price it deserves.Tune in to gain expert knowledge on creating a successful roadmap for market access in France, and discover if the "French way" aligns with your company's goals.🎧 Listen now and elevate your market access strategy! Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP PodcastsMAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de#Medtech #MarketAccess #HealthcareInnovation #FrenchHealthcareSystem #marketaccess #marketaccesspodcast
How can we overcome the complexity of market access for medical devices in Spain, Sergio Gil?
Jan 15 2024
How can we overcome the complexity of market access for medical devices in Spain, Sergio Gil?
Are you intrigued by the pulsing heart of Spain’s healthcare sector, or are you considering navigating the vibrant market of medical devices in Spain? Dive into our latest Market Access podcast episode where we unravel the complexities and dynamism of Spain’s medical landscape. 🇪🇸Join us as Sergio Gil, a seasoned veteran with over three decades in the medical device industry, shares his invaluable insights. From understanding Spain's unique regional healthcare powers to decoding the reimbursement conundrums, Sergio illuminates the path to successful market entry and what makes Spain not just culturally, but commercially captivating.Here’s a sneak peek at what you’ll discover:🔹 The striking differences between the pharmaceutical and medical device sectors in Spain.🔹 An insider’s guide to Spain’s decentralized healthcare approach and how it impacts market access.🔹 Key strategies for companies aiming to penetrate the Spanish market – straight from the expert.🔹 The burgeoning world of digital health in Spain and the emerging trends to watch out for.Whether you're a startup eyeing Spain for your next big launch or a seasoned player looking to deepen your market footprint, this episode is packed with strategic gold.✏️ Take the chance to stay connected and subscribe with your favorite podcast platform: map-market-access.captivate.fmMAP is the first and only bi-weekly #marketaccess podcast provided by MArS. For more information about MArS Market Access & Pricing Strategy GmbH visit: marketaccess-pricingstrategy.de#MedicalDevices #Healthcare #MarketAccess #Spain #Podcast #DigitalHealth #Innovation #BusinessStrategy
The Startup Guide to Navigating Healthcare Reimbursement, Featuring Ron de Graaff
Dec 1 2023
The Startup Guide to Navigating Healthcare Reimbursement, Featuring Ron de Graaff
We are thrilled to announce our latest podcast episode, featuring a riveting conversation between our CEO Dr. Stefan Walzer and the esteemed healthcare reimbursement expert, Ron de Graaff. Ron, with his deep-rooted experience starting from 1978, shares his invaluable insights on the evolution of healthcare reimbursement, a journey from simpler times to today's intricate landscape involving multiple stakeholders like health insurance companies.🔍 Key Highlights:- Ron's path from founding his company in 1985, which has since assisted over 900 entities, including governments, in understanding medical technology markets.- Challenges faced by startups in healthcare, often led by technical experts who struggle with the language and complexities of reimbursement processes.- The criticality of startups understanding both the payer perspectives and the changing requirements of reimbursement systems across Europe.- Ron's advice to startups: comprehensively understand the reimbursement system of your target market and assess if your product is likely to be reimbursable.This episode is a must-listen for anyone in the healthcare industry, particularly startups navigating the daunting world of reimbursement. Expect to gain a thorough understanding of how to strategically plan for reimbursement, the importance of being updated with current regulations, and how to choose the right market for your product.🌟 Tune in for a blend of expert insights, practical advice, and a glimpse into the future of healthcare reimbursement strategies. For more information on early reimbursement planning utilizing artificial intelligence, visit max-insights.com.✏️ Take the chance to stay connected and subscribe with your favorite podcast platform: https://lnkd.in/dyTZ3yQbMAP is the first and only bi-weekly #marketaccess podcast provided by MArS. For more information about MArS Market Access & Pricing Strategy GmbH visit: marketaccess-pricingstrategy.de#HealthcareReimbursement #StartupChallenges #MedicalTechnology #Podcast #HealthcareInnovation“
Navigating the Healthcare Startup Galaxy - key insights with Dr. Thomas Kerscher and Mark Anken.
Nov 15 2023
Navigating the Healthcare Startup Galaxy - key insights with Dr. Thomas Kerscher and Mark Anken.
🎧 Excited to share our CEO, Dr. Stefan Walzer's newest Market Access podcast episode that's nothing short of a masterclass for healthcare startups venturing into the European market!In this engaging episode, Dr. Walzer sits down with Dr. Thomas Kerscher and Mark Anken, both titans in the healthcare and pharmaceutical sectors with over two decades of experience. Currently at the helm of advantage, they're shaping the future of startups in this complex field. 🌍Key Highlights:1️⃣ Tailored Strategies: The critical need for startups to tailor their strategies based on product type and the unique healthcare landscapes of European countries.2️⃣ Realistic Approach: The importance of balancing optimism with realism, especially when pitching to well-informed investors.3️⃣ Scaling Up: The power of starting small, akin to Airbnb's model, then scaling up based on market feedback and minimal business model alterations.4️⃣ Innovation vs. Reimbursement: Understanding the delicate balance between being innovative and navigating the reimbursement strategies crucial for startup viability.💡 The duo shares invaluable insights on the significance of understanding your target customer, the nuances of entering varied European markets, and the complexities startups face in aligning their business models with healthcare policies. They stress the importance of innovation, not just for product differentiation, but as a tool to address cost pressures in healthcare systems.📈 For those in healthcare startups, this episode is a goldmine of advice on developing effective business plans, understanding investor expectations, and the imperative of global market awareness.Join us in exploring these vital topics, and gain a wealth of knowledge to propel your healthcare startup to new heights. Don't miss out on this incredible episode for a roadmap to success in the challenging yet rewarding realm of healthcare entrepreneurship.#HealthcareStartups #MarketAccess #Podcast #Innovation #BusinessStrategy #HealthcareInvestment #EuropeanMarket #DrStefanWalzer👉 Tune in to the full episode for a deep dive into these groundbreaking insights! 🎙️👇
How to navigate  complexities, Aurelie Moser: Market Access in Digital Health vs. Drugs?
Nov 1 2023
How to navigate complexities, Aurelie Moser: Market Access in Digital Health vs. Drugs?
🎙️ Exciting Podcast Episode Is Here! 🎙️In this episode of our podcast series, I'm excited to share that Stefan Walzer, a seasoned reimbursement expert, hosts the incredibly talented Amelie Moser, a business consultant with two decades of unparalleled expertise in market access!🎯 What's Happening?Immerse yourself in the fascinating world of digital health and see how it sharply contrasts with traditional drug landscapes.Grasp the challenges of moving global product strategies into local implementations, all through the lens of Aurelies experience.Navigate the crucial role of ecosystem mapping, and learn why it's important to engage all stakeholders.💡 Key Takeaways:Experience the dynamic nature of strategy adaptation — it's an evolving process, not just a set document!Join in on an enlightening discussion about the mindset shift crucial for companies making the leap from global to local viewpoints.Gain perspective on balancing qualitative vs. quantitative data for local market achievement.Uncover the unexplored complexities of digital health solutions and the challenges they pose.✨ Special Mention: Dive deep with Aurelie as she discusses her founding venture, BAMBOOSTER, and how she plays a crucial role in connecting top pharma giants with startups in the digital health and AI sectors.If the evolving landscape of healthcare piques your curiosity as much as it does mine, you won't want to miss this episode. Listen now for this enlightening conversation! 🚀🔗 Find the 3C Business Model Canvas here.✏️ Take the chance to stay connected and subscribe with your favorite podcast platform: https://lnkd.in/dyTZ3yQbMAP is the first and only bi-weekly #marketaccess podcast provided by MArS. For more information about MArS Market Access & Pricing Strategy GmbH visit: https://lnkd.in/db8aQWf#DigitalHealth #MarketAccess #Podcast #HealthcareInnovation #LocalVsGlobal #StrategiesForSuccess
AMNOG 2.0 - significant changes for the industry since January 2023, correct - Dr. Flume?
Oct 15 2023
AMNOG 2.0 - significant changes for the industry since January 2023, correct - Dr. Flume?
Join us in the latest episode where pharmacist and head of a regional physicians association, Matthias Flume, engages in a thought-provoking discussion with host Stefan Walzer, exploring the intricate tapestry of reforms enveloped within the AMNOG (Arzneimittelmarktneuordnungsgesetz) 2.0, especially scrutinizing those unveiled in 2023!🚀 Dive Deep into the Core of Pharmaceutical Reforms!Matthias unearths various pivotal changes, including the mandated discounts for products with no additional benefit rating and the perceptible adjustments in the orphan drug area, dissecting the threshold reduction for annual sales in the full regular benefit assessment. 🚀🌎 Explore the Global Impact!Navigate through their insightful discussion on how these reforms potentially sculpt Germany’s presence on the global stage, especially in the orphan drugs market, and assess Germany's unique positioning in evaluating them! 🌎💡 Illuminating the Opaqueness of Drug Pricing!Embark on a journey through the complexities and pragmatic implications of drug pricing, dissecting the nuances of arbitration boards, pricing mechanisms, and the often intricate physician prescription behaviors amidst the recent reforms. 💡🤔 Facing the Challenges Head-On!Explore the potential disconnect between pricing strategies and actual prescription practices, as our experts shed light on the vital need for enhancing transparency and communication with physicians regarding pricing negotiations and adjustments. 🤔👥 Join Matthias and Stefan as they scrutinize the germane issues of drug pricing, contemplate future adjustments within the system, and ponder upon the possible shifts influenced by the upcoming national elections and continual changes within the healthcare landscape! 👥🎧 Tune in to immerse yourself in a conversation that not only explores the multidimensional aspects of the healthcare and pharmaceutical reimbursement system but also poses potent questions regarding its future amidst regulatory and structural shifts! 🎧A journey through the dynamics of pharmaceutical pricing and reforms awaits you, amplifying both economic and patient care perspectives amidst the shifting tides of the healthcare system in Germany! Don’t miss it! 🚀🚀
Inside the Swiss decision-makers - how does the system for drugs really work, Dr. Heiner Sandmeier?
Oct 1 2023
Inside the Swiss decision-makers - how does the system for drugs really work, Dr. Heiner Sandmeier?
Listen to this podcast on your favourite podcast player: https://lnkd.in/eGemZRTi Switzerland is seen as a small but still attractive market for pharmaceuticals, even though that the Swiss decision-makers are considered as tough and sometimes even difficult. A core issue might especially be, that the assessment and negotiations primarily happen intransparently „behind the doors“. Dr. Heiner Sandmeier has been part of the drug evaluation committee advising the Swiss decision makers for over a century and opens his insights and secrets to all listeners. Some of the topics Dr. Sandmeier and reimbursement veteran Dr. Stefan Walzer discuss are as follows: What are the main drivers for a positive decision in Switzerland?Who is involved in the decision process?What are the challenges as well as possible solutions for the main issues?What are the differences to other countries in Europe?And last but not least: Why should you still consider to enter the Swiss market with an innovative pharmaceutical product?✏️ Take the chance to stay connected and subscribe with your favorite podcast platform: https://lnkd.in/dyTZ3yQbMAP is the first and only bi-weekly #marketaccess podcast provided by MArS. For more information about MArS Market Access & Pricing Strategy GmbH visit: https://lnkd.in/db8aQWf#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #pricingstrategy #negotiations #pricing #pharmaceuticals #switzerland #innovation #reimbursement
How should market access and medical affairs work together, Dr. Mike Rosenblatt?
Sep 15 2023
How should market access and medical affairs work together, Dr. Mike Rosenblatt?
Listen to this podcast on your favourite podcast player: https://lnkd.in/eGemZRTiWe are living in an age of massive medical innovation including a lot of new modalities especially in the area of ATMPs, but also beyond. Within this area, but obviously also beyond, there are core questions in the area of tensions such as the followings:- What are the differences between Clinical Development and Medical Affairs?- When should a company start telling their medical story about a new product?- What are the differences between drugs and vaccinations from a medical affairs’ perspective?- And how should market access and medical affairs ideally work together?Market access veteran Dr. Stefan Walzer and Dr. Mike Rosenblatt, one of the pioneers in Medical Affairs, Commercialisation and Market Access continued their come together in Boston in May 2023 in this epic podcast episode. Don’t miss this amazing conversation.  ✏️ Take the chance to stay connected and subscribe with your favorite podcast platform: https://lnkd.in/dyTZ3yQbMAP is the first and only bi-weekly #marketaccesspodcast provided by MArS. For more information about MArS Market Access & Pricing Strategy GmbH visit: https://lnkd.in/db8aQWf#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #medicalaffairs #pricingstrategy #negotiations#pricing #medtech #pharmaceuticals #usa #innovation #vaccination
📠 How will Switzerland make the leap from FAX machines to Digital Healthcare, Dr. Peter Indra?
Sep 1 2023
📠 How will Switzerland make the leap from FAX machines to Digital Healthcare, Dr. Peter Indra?
🎧 Listen to this podcast on your favourite podcast player: https://lnkd.in/eGemZRTi  🇨🇭Switzerland has one of the highest healthcare spendings per person across the world! At the same time, one could also say that Switzerland has also one of the best healthcare systems... 💥 … but health care expert Dr. Peter Intra calls it still a developing country in terms of digitalisation! In this MAP podcast episode, health care system veteran Dr. Stefan Walzer and Dr. Peter Indra are discussing the current state of digital health in Switzerland, possible improvements and the inspiring example of Estonia.What are we talking about, when we address the topic of digitalisation and e-health?Data + AI, which is dealing with the dataInfrastructure like electronic patient record and vaccination registriesProcesses Don't miss this inspiring conversation with spill-overs for all countries around the world. ✏️ Take the chance to stay connected and subscribe with your favorite podcast platform: https://lnkd.in/dyTZ3yQbMAP is the first and only bi-weekly #marketaccesspodcast provided by MArS. For more information about MArS Market Access & Pricing Strategy GmbH visit: https://lnkd.in/db8aQWf#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #reimbursement #digitization #digitalhealth #funding #ehealth #healthcare #digitalisation #healthservices #switzerland
How does an optimized communication strategy look like, Dr. Arne Näveke?
Aug 15 2023
How does an optimized communication strategy look like, Dr. Arne Näveke?
Listen to this podcast on your favourite podcast player: https://lnkd.in/eGemZRTiCompanies, including start-ups, are usually focused solely on the development of the product and/or the technical platform in the early days. As understandable and important these aspects are, if they don’t start to think about their public communications strategy from the very beginning, they might be in danger of failing.                                                           Already in the very early stages of the development of pharmaceuticals or med tech products, companies need to think about the following key points: Will patients need and want the new product?Will physicians prescribe it?Will payers pay for it? And thus they should come up with a convincing value story towards all stakeholders as only if they could convince all of these, investors will see the potential return of investment! But ultimately, all of that needs to be communicated… The reimbursement veteran Dr. Stefan Walzer these and more aspects around (global and local) communication with the communication expert Dr. Arne Näveke. ✏️ Take the chance to stay connected and subscribe with your favorite podcast platform: https://lnkd.in/dyTZ3yQbMAP is the first and only bi-weekly #marketaccesspodcast provided by MArS. For more information about MArS Market Access & Pricing Strategy GmbH visit: https://lnkd.in/db8aQWf#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #reimbursement #pricingstrategy #negotiations #pricing #medtech #pharmaceuticals #communications #funding #medicaldevices #germany